1. Home
  2. MAA vs BBIO Comparison

MAA vs BBIO Comparison

Compare MAA & BBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MAA
  • BBIO
  • Stock Information
  • Founded
  • MAA 1977
  • BBIO 2015
  • Country
  • MAA United States
  • BBIO United States
  • Employees
  • MAA N/A
  • BBIO N/A
  • Industry
  • MAA Real Estate Investment Trusts
  • BBIO Biotechnology: Pharmaceutical Preparations
  • Sector
  • MAA Real Estate
  • BBIO Health Care
  • Exchange
  • MAA Nasdaq
  • BBIO Nasdaq
  • Market Cap
  • MAA 17.3B
  • BBIO 8.0B
  • IPO Year
  • MAA 1994
  • BBIO 2019
  • Fundamental
  • Price
  • MAA $151.01
  • BBIO $46.47
  • Analyst Decision
  • MAA Buy
  • BBIO Strong Buy
  • Analyst Count
  • MAA 20
  • BBIO 14
  • Target Price
  • MAA $176.25
  • BBIO $60.21
  • AVG Volume (30 Days)
  • MAA 1.0M
  • BBIO 3.3M
  • Earning Date
  • MAA 07-30-2025
  • BBIO 07-31-2025
  • Dividend Yield
  • MAA 4.02%
  • BBIO N/A
  • EPS Growth
  • MAA 0.75
  • BBIO N/A
  • EPS
  • MAA 4.81
  • BBIO N/A
  • Revenue
  • MAA $2,196,688,000.00
  • BBIO $127,415,000.00
  • Revenue This Year
  • MAA $2.37
  • BBIO $107.34
  • Revenue Next Year
  • MAA $3.97
  • BBIO $49.48
  • P/E Ratio
  • MAA $31.35
  • BBIO N/A
  • Revenue Growth
  • MAA 1.55
  • BBIO N/A
  • 52 Week Low
  • MAA $138.89
  • BBIO $21.72
  • 52 Week High
  • MAA $173.38
  • BBIO $46.80
  • Technical
  • Relative Strength Index (RSI)
  • MAA 50.52
  • BBIO 71.64
  • Support Level
  • MAA $149.07
  • BBIO $41.80
  • Resistance Level
  • MAA $152.83
  • BBIO $46.80
  • Average True Range (ATR)
  • MAA 2.68
  • BBIO 1.44
  • MACD
  • MAA 0.64
  • BBIO 0.09
  • Stochastic Oscillator
  • MAA 76.30
  • BBIO 94.00

About MAA Mid-America Apartment Communities Inc.

Mid-America Apartment Communities Inc or MAA, is a real estate investment trust engaged in the acquisition, operation, and development of multifamily apartment communities located in the southeastern and southwestern United States. The company operates two reportable segments; Same Store includes communities that the Company has owned and have been stabilized for at least a full 12 months as of the first day of the calendar year and Non-Same Store and Other includes recently acquired communities, communities being developed or in lease-up, communities that have been disposed of or identified for disposition, communities that have experienced a casualty loss and stabilized communities that do not meet the requirements to be Same Store communities.

About BBIO BridgeBio Pharma Inc.

BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.

Share on Social Networks: